Research Article Co-Authored on Ferroptosis MoA Analysis Published in Communications Biology

2025.04.08

Protein covariation networks for elucidating ferroptosis inducer mechanisms and potential synergistic drug targets

Publication

Mechanism of action (MoA) analysis of hit compounds identified through phenotypic screening is a crucial step in drug discovery and the elucidation of novel biological mechanisms. While various MoA analysis techniques have been developed, none can guarantee absolute success, highlighting the need for new approaches.
In this study, we successfully elucidated the MoA of ferroptosis-inducing compounds, a form of regulated cell death, using the PLOM-CON analysis method (Protein Localization and Modification-based Covariation Network analysis method). This method captures changes in the “quantity, quality, and localization” of proteins induced by drug treatment via fluorescent antibody staining. These changes are then visualized as covariation networks based on their temporal coordination.
Furthermore, the covariation network data obtained through this approach suggested novel combination therapy strategies. This study demonstrates that PLOM-CON analysis is a powerful tool for compound MoA analysis and has the potential to expand research in combination drug therapy.

Axcelead DDP Solution
In addition to our phenotypic screening services, Axcelead DDP offers mechanism of action (MoA) analysis services using fingerprinting and chemical proteomics.
If you are considering a new phenotypic screening approach or facing challenges in identifying the MoA of your compounds, please feel free to contact us. We are here to support your drug discovery research.